Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06194344 · ClinicalTrials.gov registry record · NA

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis

A NA study of Psychosis, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06194344: Recruiting NA study of Psychosis, sponsored by The University of Texas Health Science Center, Houston.

NCT06194344 is a NA study of Psychosis that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 40 participants, below the 178-participant average among 35 other Psychosis trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06194344, a NA study of Psychosis, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see how feasible is the use of compact EEG and paired audio technology to administer sleep interventions for inpatients with psychosis, to see if individuals that receive individualized technology-based sleep interventions experience improvements in sleep quality and to see if individuals that receive individualized technology-based sleep interventions experience improvements in symptomatology

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Individualized imagery

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-03-05
Est. Completion 2026-06-01
Phase NA

What NCT06194344 shows while recruiting

NCT06194344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 178-participant average among 35 other Psychosis trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Psychosis appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT06194344 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06194344 about?

NCT06194344 is a clinical study titled "The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis". The purpose of this study is to see how feasible is the use of compact EEG and paired audio technology to administer sleep interventions for inpatients with psychosis, to see if individuals that receive individualized technology-based sleep interventions experience improvements in sleep quality and ...

What is the current status of trial NCT06194344?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-03-05. Estimated completion is 2026-06-01.

What conditions does trial NCT06194344 study?

This clinical trial studies the following conditions: Psychosis.

What interventions are being tested in trial NCT06194344?

The interventions under investigation include: Control (BEHAVIORAL), Individualized imagery (BEHAVIORAL).

Who is sponsoring clinical trial NCT06194344?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06194344 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06194344's enrollment target sits among peer trials

40 28th of 35 higher than 8 of 35 other Psychosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Psychosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06194344, the US trial registry maintained by the National Library of Medicine. NCT06194344 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.